TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Total Assets

Annual figures by fiscal year, from SEC filings.

2014: $73.06M2015: $197.22M2016: $199.13M2017: $397.64M2018: $457.11M2019: $341.28M2020: $358.66M2021: $339.41M2022: $260.89M2023: $201.79M2024: $120.53M2025: $151.57M$151.57M
2014Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$151.57M+25.7%
2024$120.53M-40.3%
2023$201.79M-22.7%
2022$260.89M-23.1%
2021$339.41M-5.4%
2020$358.66M+5.1%
2019$341.28M-25.3%
2018$457.11M+15.0%
2017$397.64M+99.7%
2016$199.13M+1.0%
2015$197.22M+169.9%
2014$73.06M—